EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 217 filers reported holding EDITAS MEDICINE INC in Q2 2018. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $46,000 | +27.8% | 1,567 | 0.0% | 0.00% | – |
| Q3 2019 | $36,000 | -16.3% | 1,567 | -10.3% | 0.00% | – |
| Q2 2019 | $43,000 | +10.3% | 1,746 | +9.4% | 0.00% | – |
| Q1 2019 | $39,000 | +5.4% | 1,596 | -1.3% | 0.00% | – |
| Q4 2018 | $37,000 | -21.3% | 1,617 | +9.0% | 0.00% | – |
| Q3 2018 | $47,000 | -89.5% | 1,483 | -88.1% | 0.00% | -100.0% |
| Q2 2018 | $448,000 | +11.2% | 12,514 | +3.1% | 0.01% | 0.0% |
| Q1 2018 | $403,000 | +607.0% | 12,141 | +552.4% | 0.01% | +500.0% |
| Q4 2017 | $57,000 | +46.2% | 1,861 | +16.2% | 0.00% | 0.0% |
| Q3 2017 | $39,000 | +30.0% | 1,601 | -11.1% | 0.00% | 0.0% |
| Q2 2017 | $30,000 | -16.7% | 1,801 | +12.6% | 0.00% | 0.0% |
| Q1 2017 | $36,000 | +1100.0% | 1,600 | +700.0% | 0.00% | – |
| Q3 2016 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |